Full Length Research Paper
References
|
Andrews JM (2005). BSAC standardized disc susceptibility testing metho(version 4). J. Antimicrob. Chemother. 56: 60-76. Crossref |
||||
| Anil VK, Vishnu S, Kavitha R, Shamsul K (2011). The phenotypic detection of carbapenemase in meropenem resistant Acinetobacter calcoaceticus-baumannii complex in tertiary care hospital in South India. J. Clin. Diagnostic Res. 5(2): 223-226. | ||||
|
Brown S, Amyes SG (2005). The sequences of seven class D beta-lactamases isolated from carbapenem-resistant Acinetobacter baumanniif rom four continents. Clin. Microbiol. Infect. 11:326–329. Crossref |
||||
|
Brown S, Amyes SG (2006). OXA (beta)-lactamases in Acinetobacter: the story so far. J. Antimicrob. Chemother.57:1–3. Crossref |
||||
|
Brown S, Young HK, Amyes SG (2005). Characterization of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin. Microbiol. Infect. 11:15–23. Crossref |
||||
| CLSI (2006). Performance standards for antimicrobial susceptibility testing. 16th informational supplements. CLSI document.M2 Clinical and Laboratory Standards Institute,Wayne, PA. USA. | ||||
| CLSI (2010). Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement, document M100-S20, Clinical and Laboratory Standards Institute, Wayne, PA. USA. | ||||
| Collee JG, Fraser AG, Simmonus A (1996). Tests for identification of in: Mackie & McCartney, Practical Medical Microbiology,14th., Churchill Livingstone In, New York, USA. | ||||
|
Dijkshoorn L, Aucken HP, Gerner SP, Janssen ME, Kaufmann J, Garaizar J, Pitt TL (1996). Comparison of outbreak and non- out-break Acinetobacter baumannii strains by genotypic and phenotypic methods. J. Clin. Microbiol. 34:1519–1525. Pubmed |
||||
|
Dijkshoorn L, VanAken E, Shunburne L, Bernards AT, Nemes A, Tower KJ (2005). Prevalence of Acinetobacter baumannii and other spp in faecal samples from non-hospitalised individuals. Clin. Microbiol. Infect. 11: 329-332. Crossref |
||||
|
Feizabadi MM, Fathollahzadeh B, Taherikalkalani M, Rasoolinejod M, Sadeghifard N, Aligholi M, Soroush S, Mohammadi S (2008): Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacterspp. Isolated from patients at Tahran hospitals. Jpn. J. Infect. Dis. 61:274-278. Pubmed |
||||
| Hanaa A, Somia M, Heba A, Randa S (2010). Bacteriological Study on Acinetobacter species as Nosocmial Pathogens in Zagzig University Hospitals . Thesis of Master degree in Zagzig University Hospitals. | ||||
| Hashem S, Fekry S, Mohammed A, Doaa S (2011). Multidrug resistant Egyptian isolates of Acinetobacter baumannii. J. Am. Sci. 7(1). | ||||
|
He’ritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P (2005). Characterization of the naturally occurring oxacillinase of Acinetobacterbaumannii. Antimicrob. Agents Chemother. 49:4174–4179. Crossref |
||||
|
Koeleman JG, Stoof MJ, Van der B, Vandenbroucke G, Savelkoul PH (2001). Identification of epidemic strains of Acinetobacterbaumanniiby integrase gene PCR. J. Clin. Microbiol. 39:8–13. Crossref |
||||
|
Limansky AS, Mussi MA, Viale AM (2002). Loss of a 29-kilodalton outer membrane protein in Acinetobacterbaumannii is associated with imepenem resistance. J. Clin. Microbiol. 40: 4776-4778. Crossref |
||||
|
Livermore DM (2002). The impact of carbapenemases on antimicrobial development and therapy. Curr. Opin. Invest. Drugs. 3: 218-24. Pubmed |
||||
|
Martinez-Freijo P, Fluit AC, Schmitz FJ, Grek VS, Verhoef J, Jones ME (1998). Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J. Antimicrob. Chemother. 42:689–696. Crossref |
||||
| Muthusamy D, Boppe A (2012). Phenotypic Methods for the Detection of Various Betalactamases in Carbapenem Resistant Isolates of Acinetobacterbaumanii at a Tertiary Care Hospital in South India. J. Clin. Diag. Res. 6:970-973. | ||||
|
Navon-Venezia S, Ben-Ami R, Carmeli Y (2005). Update on Pseudomonas aeruginosa and Acinetobacterbaumannii infections in thehealthcare setting. Curr. Opin. Infect. Dis. 18: 306–313. Crossref |
||||
|
Peleg AY, Seifert H, Paterson DL (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin. Micro Rev. 21: 538-82. Crossref |
||||
|
Poirel L, Menuteau O, Agoli N, Catoen C, Nordmann P (2003). Out-break of extended spectrum beta-lactamase VEB-1-producing iso-lates of Acinetobacter baumannii in a French Hospital. J. Clin. Microbiol. 41: 3542-3547. Crossref |
||||
| Renu G, Rajeev T, Smita S (2010). Existence of Metallo beta lacta-mases in carbapenem susceptible Gram negative bacilli: a cause for concern. J. Clin. Diag. Res. 4: 2679-2684. | ||||
|
Stokes HW, Hall RM (1989). A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol. 3: 1669–1683. Crossref |
||||
|
Takagi EH, Lincopan N, Cassettari VC, Passadore LF, Mamizuka EM, Martinez MB (2009). Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital. Br. J. Microbiol. 40:339-341. Crossref |
||||
|
Turton JF, Kaufmann ME, Glover J, Coelho JM, Warner M, Pike R, Pitt TL (2005). Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J. Clin. Microbiol. 43:3074–3082. Crossref |
||||
|
Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL (2006a). The role of ISAbal in expression of OXA carbapenamase genes in Acinetobacter baumanii. FEMS Microbiol. Lett. 258:72-77 Crossref |
||||
|
Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL (2006b). Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carrbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44(8): 2974-2976. Crossref |
||||
|
Valenza G, Joseph B, Elias J, Claus H, Oesterlein A (2010). First survey of metallo-β-Lactamases in clinical isolates ofPseudomonasaeruginosa in a German University Hospital. Antimicrob. Agents Chemother. 54: 3493-3497. Crossref |
||||
|
Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G, Verschraegen G (1995). Identification of Acinetobactergenomic species by amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 33:11–15. Pubmed |
||||
|
Villegas MV, Hartstein AI (2003). Acinetobacter outbreaks. Infect. Control Hosp. Epidemiol. 24:284-295. Crossref |
||||
|
Walsh TR, Toleman MA, Poirel L, Nordmann P (2005). Metallo-ß- actamases: the quiet before the storm? Clin. Microbiol. Rev. 18: 306- 325. Crossref |
||||
|
Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SGB, Livermore DM (2006). Multiplex PCR for genes enco-ding prevalent OXA carbapenemases in Acinetobacterspp. Int. J. Antimicrob. Agents 27:351–353. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
